G. Waterer (Perth (WA), Australia), M. Kolditz (Dresden, Germany)
Results of vaccination against pneumococcal infection in patients with chronic heart failure
A. Kraposhina (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Demko (Krasnoyarsk (Krasnoyarsk), Russian Federation), N. Gordeeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Soloveva (Krasnoyarsk (Krasnoyarsk), Russian Federation), M. Mamaeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), E. Sobko (Krasnoyarsk (Krasnoyarsk), Russian Federation)
|   |
Incidence of Cardiac Complications after Hospitalisation for Community Acquired Pneumonia: A Large Population-based Cohort Study
V. Baskaran (Nottingham (Nottinghamshire), United Kingdom), T. Mckeever (Nottingham (Nottinghamshire), United Kingdom), W. Lim (Nottingham (Nottinghamshire), United Kingdom)
| |
Comunity acquired legionella pneumonia: cardiovascular events and survival
L. Serrano Fernandez (Barakaldo, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), A. Gomez Bonilla (Barakaldo, Spain), M. Garcia Moyano (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), B. Gomez Crespo (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), A. Urrutia Gajate (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain)
| |
Endothelial dysfunction and its corrections in patients with severe community-aquired pneumonia (CAP)
K. Bielosludtseva (Dniepropetrovsk, Ukraine), M. Krykhtina (Dnipro, Ukraine), T. Kirieieva (Dniepropetrovsk, Ukraine), T. Pertseva (Dniepropetrovsk, Ukraine)
| |
Community acquired pneumonia: an increased risk for subsequent cardiovascular events?
A. Fonseca (Vila Nova de Gaia, Portugal), M. Sá Marques (Vila Nova de Gaia, Portugal), E. Silva (Vila Nova de Gaia, Portugal), T. Shiang (Vila Nova de Gaia, Portugal), M. Vanzeller (Vila Nova de Gaia, Portugal), C. Ribeiro (Vila Nova de Gaia, Portugal)
| |
Acute Pneumonia and PSI: is it posible to prevent a cardiovascular event?
J. Garcia Fuertes (Vitoria-Gasteiz, Spain), J. Poyo Molina (Vitoria-Gasteiz, Spain), I. Juanes Dominguez (Vitoria-Gasteiz, Spain), M. Lahidalga Mugica (Vitoria-Gasteiz, Spain), M. Bello Mora (Vitoria-Gasteiz, Spain), A. Alonso Gomez (Vitoria-Gasteiz, Spain), L. Tojal Sierra (Vitoria-Gasteiz, Spain), J. Lobo Beristain (Vitoria-Gasteiz, Spain)
| |
Differences in prognosis and outcome in patients with pneumococcal pneumonia and new onset atrial arrhythmia: impact of the time and duration of the arrhythmia
L. Ruiz Iturriaga (Barakaldo, Spain), L. Serrano Fernandez (Barakaldo, Spain), L. Martinez-Indart (Barakaldo, Spain), A. Gomez Bonilla (Barakaldo, Spain), A. Artaraz Ereño (Galdakao, Spain), J. Andia Iturrate (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), P. España Yandiola (Galdakao, Spain), R. Zalacain Jorge (Barakaldo, Spain)
| |
Meta-analysis of Acute Coronary Syndrome in Patients with Community-Acquired Pneumonia
V. Baskaran (Nottingham (Nottinghamshire), United Kingdom), S. Quammie (Nottingham (Nottinghamshire), United Kingdom), H. Lawrence (Nottingham (Nottinghamshire), United Kingdom), D. Ashton (Nottingham (Nottinghamshire), United Kingdom), W. Lim (Nottingham (Nottinghamshire), United Kingdom), T. Mckeever (Nottingham (Nottinghamshire), United Kingdom)
| |
Relation between respiratory diseases and the development of cardiovascular events in patients with respiratory viral infection
M. Zambrano Chacon (MADRID, Spain), L. Esteban-Lucía (MADRID, Spain), A. Izquierdo Pérez (MADRID, Spain), L. Nieto Roca (MADRID, Spain), A. Venegas Rodríguez (MADRID, Spain), C. García Talavera (MADRID, Spain), A. Pello Lázaro (MADRID, Spain), Á. Aceña Navaroo (MADRID, Spain), F. Villar Álvarez (MADRID, Spain)
| |
Mean platelet volume changes in patients with nosocomial pneumonia.
V. Volchkov (St. Petersburg, Russian Federation), A. Vasilytsina (St. Petersburg, Russian Federation), V. Afonchikov (St. Petersburg, Russian Federation), E. Volchkova (St. Petersburg, Russian Federation), D. Larin (St. Petersburg, Russian Federation)
| |
Active monitoring of adverse drug reactions to the use of beta-lactam antibiotics in the treatment of community-acquired pneumonia
E. Torgunakova (Krasnoyarsk, Russian Federation), E. Bochanova (Krasnoyarsk, Russian Federation), I. Demko (Krasnoyarsk, Russian Federation), A. Kraposhina (Krasnoyarsk, Russian Federation), E. Kurts (Krasnoyarsk, Russian Federation)
| |
Infectious COPD exacerbations and value of chest radiography
Y. González (Buenos Aires, Argentina), F. Di Tullio (Buenos Aires, Argentina), G. Ernst (Buenos Aires, Argentina), M. Bosio (Buenos Aires, Argentina), E. Borsini (Buenos Aires, Argentina), A. Salvado (Buenos Aires, Argentina), J. Pascua (Buenos Aires, Argentina), P. Oyhamburu (Buenos Aires, Argentina), G. Robaina (Buenos Aires, Argentina)
| |
Comparative prospective cohort study of the efficacy and safety according to dose of Ceftriaxone in community-acquired pneumonia
Y. Nakanishi (Kurashiki, Japan), A. Ito (Kurashiki, Japan), H. Tachibana (Kyoto, Japan), T. Ishida (Kurashiki, Japan), M. Mitsui (Kurashiki, Japan)
| |
Clinical features and antimicrobial resistance pattern of patients with CAP caused by K. pneumoniae in Jakarta, Indonesia
G. Amanda (Jakarta, Indonesia), D. Sutoyo (Jakarta, Indonesia), E. Burhan (Jakarta, Indonesia), B. Haryanto (Jakarta, Indonesia), W. Tafroji (Jakarta, Indonesia), D. Safari (Jakarta, Indonesia)
| |
Therapeutic failure among incident users of ß-lactam antibiotics: a real-world, cohort study, in primary care in Italy
E. Marconi (firenze, Italy), A. Rossi (firenze, Italy), C. Cricelli (firenze, Italy), F. Lapi (firenze, Italy)
| |
New prediction score without subjective parameters for community-acquired Legionella pneumonia
S. Yokoe (Kurashiki- city, Japan), A. Ito (Kurashiki- city, Japan), H. Tachibana (Kyoto-city, Japan), M. Mitsui (Kurashiki- city, Japan), Y. Nakanishi (Kurashiki- city, Japan), T. Ishida (Kurashiki- city, Japan)
| |
Use of corticosteroids in patients with severe CAP admitted to ICU, experience in a real-life setting.
A. Ceccato (barcelona, Spain), P. Di Giannatale (Chieti-Pescara, Italy), E. Barbeta (Barcelona, Spain), S. Nogas (Genova, Italy), P. Oscanoa (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), M. Ferrer (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia
S. Pascual Guardia (Barcelona, Spain), J. Marin Corral (Barcelona, Spain), F. Amati (Milan, Italy), S. Aliberti (Milan, Italy), J. Gea (Barcelona, Spain), N. J.Soni (San Antonio, United States of America), A. Rodríguez (Tarragona, Spain), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), A. Antonio (San Antonio, United States of America), M. Restrepo (San Antonio, United States of America)
| |